This article was written by Follow Contributing analyst to the iREIT+Hoya Capital investment group. The Dividend Collectuh is not a registered investment professional nor...
A nice counter-trade The latest gathering of the world’s political and business elite, plus the usual smattering of celebrities, is taking place this week...
This article was written by Follow A leading global provider of benchmarks, analytics, and data solutions with multi-asset capabilities FTSE Russell’s solutions offer a...
BUD Has Fallen To The Cancel Culture We have previously covered Anheuser-Busch InBev SA/NV (BUD) in April 2023, suggesting that the controversy after the...
Introduction As a dividend growth investor, I seek investment opportunities in income-producing assets, mainly stocks. I usually add to existing positions when I find...
Introduction Founded in 2008, BioNTech (NASDAQ:BNTX) is an international leader in immunotherapy, aimed at innovating treatments for cancer, infectious diseases, and other severe illnesses....
One of my favorite financial planning clients represents a story that is part success, part sadness. Betty, we’ll call her, married young and became...
Annuities are setting sales records, thanks to higher interest rates, lower stock prices, and aging Baby Boomers. It’s been years since annuities were able...
Investment thesis Our current investment thesis is: IDEXX growth and margins are highly attractive, with no real financial downsides. Commercially, IDEXX has transitioned toward...
Investment Thesis CME Group (NASDAQ:CME) is currently down over 25% from its all-time high last year, as the financial companies continue to face pressure...